To evaluate the role of HGF pathway activation in breast cancer disparities, we assessed a 38-gene HGF gene expression signature in invasive breast cancer cases in a population-based resource, the Carolina Breast Cancer Study. This evidence concerns the gene HGF and invasive breast carcinoma.